LYTIR

Company · VCYT

Veracyte, Inc.

Name as listed on its exchange; filed with the SEC as VERACYTE, INC.

Nasdaq's symbol directory lists VCYT on Nasdaq as “Veracyte, Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders sold on 11 occasions ($3.1M); 5 planned-sale notices; 1 filing by holders of 5% or more; 2 congressional trade disclosures; 2 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $3.1M in total.Jun: Insider sales $197KSep: Insider sales $1.7MOct: Insider sales $1.2MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $3.1M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. EASTHAM KARIN sold on 2 days all under a 10b5-1 plan latest Oct 27, 2026 sold $940K
  2. Holstein Jens sold on 3 days all under a 10b5-1 plan latest Oct 27, 2026 sold $932K
  3. Febbo Phillip G., Chief Scientific & Med Officer sold on 1 day all under a 10b5-1 plan latest Sep 4, 2026 sold $564K
  4. Bhanji Muna sold on 2 days all under a 10b5-1 plan latest Oct 19, 2026 sold $162K
  5. Leite John, Global Chief Commercial Off sold on 1 day all under a 10b5-1 plan latest Sep 21, 2026 sold $161K
  6. Chambers Rebecca, Chief Financial Officer sold on 1 day all under a 10b5-1 plan latest Sep 4, 2026 sold $157K
  7. McGuire Annie, EVP, General Counsel sold on 1 day all under a 10b5-1 plan latest Sep 4, 2026 sold $140K
Every trade (11)
  1. SELLEASTHAM KARIN sold Oct 27, 2026 14,850 shares 10b5-1 plan (scheduled) filing $743K
  2. SELLHolstein Jens sold Oct 27, 2026 7,500 shares 10b5-1 plan (scheduled) filing $375K
  3. SELLBhanji Muna sold Oct 19, 2026 1,864 shares 10b5-1 plan (scheduled) filing $81K
  4. SELLHolstein Jens sold Sep 24, 2026 7,500 shares 10b5-1 plan (scheduled) filing $352K
  5. SELLLeite John, Global Chief Commercial Off sold Sep 21, 2026 4,015 shares 10b5-1 plan (scheduled) filing $161K
  6. SELLHolstein Jens sold Sep 14, 2026 5,000 shares 10b5-1 plan (scheduled) filing $205K
  7. SELLFebbo Phillip G., Chief Scientific & Med Officer sold Sep 4, 2026 13,110 shares 2 legs combined 10b5-1 plan (scheduled) filing $564K
  8. SELLChambers Rebecca, Chief Financial Officer sold Sep 4, 2026 3,652 shares 2 legs combined 10b5-1 plan (scheduled) filing $157K
  9. SELLMcGuire Annie, EVP, General Counsel sold Sep 4, 2026 3,254 shares 2 legs combined 10b5-1 plan (scheduled) filing $140K
  10. SELLBhanji Muna sold Sep 1, 2026 1,864 shares 10b5-1 plan (scheduled) filing $80K
  11. SELLEASTHAM KARIN sold Jun 18, 2026 3,729 shares 2 legs combined 10b5-1 plan (scheduled) filing $197K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. KARIN EASTHAM filed Oct 27, 2026 Director 14,850 shares planned sale date 10/27/2026 filing $716K
  2. JENS HOLSTEIN filed Oct 27, 2026 Director 7,500 shares planned sale date 10/27/2026 filing $375K
  3. JENS HOLSTEIN filed Sep 24, 2026 Director 7,500 shares planned sale date 09/24/2026 filing $352K
  4. JOHN LEITE filed Sep 21, 2026 Officer 4,015 shares planned sale date 09/21/2026 filing $160K
  5. JENS HOLSTEIN filed Sep 14, 2026 Director 5,000 shares planned sale date 09/14/2026 filing $205K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. FMR LLC filed Nov 5, 2026 Schedule 13G/A passive 6,172,996 shares filing 7.7%

Congress · STOCK Act

The Althing

Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.

  1. Gilbert Cisneros (D-CA31): Purchase Mar 3, 2026 reported Apr 7, 2026 one of 141 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  2. Gilbert Cisneros (D-CA31): Purchase Feb 18, 2026 reported Mar 9, 2026 one of 85 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition; Other events filing Nov 4, 2026
  2. Entry into a material definitive agreement; Completion of acquisition or disposition of assets; Regulation FD disclosure filing Sep 14, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.